The Nitrosamine “Saga”: Lessons Learned from Five Years of ScrutinyRaphael Nudelman, Anne-Laure Werner, Joerg Schlingemann et al.|Organic Process Research & Development|2023Cited by 78
Control of N-nitrosamine impurities in drug products: Progressing the current CPCA framework and supporting the derivation of robust compound specific acceptable intakesDavid J. Ponting, Robert Thomas, Andreas Czich et al.|Regulatory Toxicology and Pharmacology|2024Cited by 13